Ag. Rossi et al., HUMAN CIRCULATING EOSINOPHILS SECRETE MACROPHAGE-MIGRATION INHIBITORYFACTOR (MIF) - POTENTIAL ROLE IN ASTHMA, The Journal of clinical investigation, 101(12), 1998, pp. 2869-2874
Macrophage migration inhibitory factor (MIF) is a potent proinflammato
ry mediator that has been shown to potentiate lethal endotoxemia and t
o play a potentially important regulatory role in human acute respirat
ory distress syndrome (ARDS), We have investigated whether eosinophils
are an important source of MIF and whether MIF may be involved in the
pathophysiology of asthma, Unstimulated human circulating eosinophils
were found to contain preformed MIF. Stimulation of human eosinophils
with phorbol myristate acetate in vitro yielded significant release o
f MIF protein. For example, eosinophils stimulated with phorbol myrist
ate acetate (100 nM, 8 h, 37 degrees C) released 1,539 +/- 435 pg/10(6
) cells of MTF, whereas unstimulated cells released barely detectable
levels (< 142 pg/10(6) cells, mean +/- SEM, n = 8), This stimulated re
lease was shown to be (a) concentration- and time-dependent, (b) parti
ally blocked by the protein synthesis inhibitor cycloheximide, and (c)
significantly inhibited by the protein kinase C inhibitor Ro-31,8220.
In addition, we show that the physiological stimuli C5a and IL-5 also
cause significant MIF release. Furthermore, bronchoalveolar lavage fl
uid obtained from asthmatic patients contains significantly elevated l
evels of MIF as compared to nonatopic normal volunteers (asthmatic, 79
7.5 +/- 92 pg/ml; controls, 274 +/- 91 pg/ml). These results highlight
the potential importance of MIF in asthma and other eosinophil-depend
ent inflammatory disorders.